P2.14. First-Line Envafolimab plus Carboplatin-etoposide in Extensive-Stage Small-Cell Lung Cancer: a Single-Arm Phase II Study - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Shengjie Sun
Meta Tag
Speaker Shengjie Sun
Topic SCLC & Neuroendocrine Tumors: First Line Therapy
Keywords
phase II study
China
efficacy
safety
envafolimab
carboplatin
etoposide
extensive-stage small-cell lung cancer
treatment-naïve patients
progression-free survival
Powered By